IL2 and neoplasm: On the one hand, IL-2-stimulated CD226−/− NK cells could perform missing self-reactions against tumour cells in vitro, while on the other hand CD226−/− mice exhibited slightly reduced capacity for missing self rejection of MHC-I− cells in vivo.